nach oben

Journal of Community Health

Erschienen in:

17.07.2019 | Original Paper

A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities

verfasst von: Cathy J. Reback, Kirsty A. Clark, Dennis Rünger, Anne E. Fehrenbacher

Erschienen in: Journal of Community Health | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Transgender women and MSM experience many stigma-related syndemic conditions that exacerbate HIV incidence and prevalence rates. While PrEP is an effective biomedical intervention to reduce HIV transmission, uptake and adherence of PrEP is low among transgender women and MSM experiencing multiple syndemic health disparities. This study tested the feasibility, acceptability and effectiveness of A.S.K.-PrEP (AssistanceServicesKnowledge-PrEP), a five-session peer navigator program, designed to link transgender women and MSM to PrEP. From September 2016 to March 2018, 187 participants (transgender women = 58; MSM = 129) enrolled. Results demonstrated that approximately 90% of transgender women and MSM were linked to PrEP; MSM linked more quickly [KW χ²(1) = 10.9, p < .001]. Most transgender women (80%) and MSM (70%) reported they were still taking PrEP at the 90-day follow-up evaluation. Findings indicated that A.S.K.-PrEP is a promising intervention for PrEP linkage, uptake and preliminary adherence among transgender women and MSM.

Centers for Disease Control and Prevention. (2017). Fact sheet: HIV among gay and bisexual men. Atlanta, GA: Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/hiv/group/msm/index.html.

Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13(3), 214–222.PubMed

Centers for Disease Control and Prevention. (2017). Fact sheet: HIV among transgender people. Atlanta, GA: Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/hiv/group/gender/transgender/index.html.

Reback, C. J., Clark, K., Holloway, I. W., & Fletcher, J. B. (2018). Health disparities, risk behaviors and healthcare utilization among transgender women in Los Angeles County: A comparison from 1998–1999 to 2015–2016. AIDS and Behavior, 22(8), 2524–2533.PubMedPubMedCentral

Brennan, J., Kuhns, L. M., Johnson, A. K., et al. (2012). Syndemic theory and HIV-related risk among young transgender women: The role of multiple, co-occurring health problems and social marginalization. American Journal of Public Health, 102(9), 1751–1757.PubMedPubMedCentral

Reback, C. J., & Fletcher, J. B. (2014). HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS and Behavior, 18(7), 1359–1367.PubMedPubMedCentral

Beyrer, C., Sullivan, P., Sanchez, J., et al. (2013). The increase in global HIV epidemics in MSM. Aids, 27(17), 2665–2678.PubMed

Fletcher, J. B., & Reback, C. J. (2017). Mental health disorders among homeless, substance-dependent men who have sex with men. Drug and Alcohol Review, 36(4), 555–559.PubMed

Reback, C. J., & Fletcher, J. B. (2017). Outcomes from a homegrown HIV prevention program for extremely high-risk, substance-using men who have sex with men with multiple health disparities. Journal of Gay & Lesbian Social Services, 29(2), 167–181.

10.

Santos, G. M., Wilson, E. C., Rapues, J., Macias, O., Packer, T., & Raymond, H. F. (2014). HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sexually Transmitted Infections, 90(5), 430–433.PubMed

11.

Shoptaw, S., & Reback, C. J. (2007). Methamphetamine use and infectious disease-related behaviors in men who have sex with men: Implications for interventions. Addiction, 102, 130–135.PubMed

12.

Stall, R., Mills, T. C., Williamson, J., et al. (2003). Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. American Journal of Public Health, 93(6), 939–942.PubMedPubMedCentral

13.

Chapin-Bardales, J., Rosenberg, E. S., & Sullivan, P. S. (2017). Trends in racial/ethnic disparities of new AIDS diagnoses in the United States, 1984–2013. Annals of Epidemiology, 27(5), 329–334.PubMedPubMedCentral

14.

Clark, H., Babu, A. S., Wiewel, E. W., Opoku, J., & Crepaz, N. (2017). Diagnosed HIV infection in transgender adults and adolescents: Results from the National HIV Surveillance System, 2009–2014. AIDS and Behavior, 21(9), 2774–2783.PubMedPubMedCentral

15.

Maulsby, C., Millett, G., Lindsey, K., et al. (2014). HIV among black men who have sex with men (MSM) in the United States: A review of the literature. AIDS and Behavior, 18(1), 10–25.PubMed

16.

Grant, R. M., Anderson, P. L., McMahan, V., et al. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829.PubMedPubMedCentral

17.

Huang, X., Hou, J., Song, A., et al. (2018). Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: A systematic review and meta-analysis. Frontiers in pharmacology, 9(799), 1–11.

18.

Grant, R. M., Lama, J. R., Anderson, P. L., et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.PubMed

19.

Buchbinder, S. P. (2018). Maximizing the benefits of HIV preexposure prophylaxis. Topics in Antiviral Medicine, 25(4), 138.PubMedPubMedCentral

20.

Spinner, C. D., Boesecke, C., Zink, A., et al. (2016). HIV pre-exposure prophylaxis (PrEP): A review of current knowledge of oral systemic HIV PrEP in humans. Infection, 44(2), 151–158.

21.

Anderson, P. L., Glidden, D. V., Liu, A., et al. (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151), 151ra125–151ra125.PubMedPubMedCentral

22.

Baxi, S. M., Vittinghoff, E., Bacchetti, P., et al. (2018). Comparing pharmacologic measures of tenofovir exposure in a US pre-exposure prophylaxis randomized trial. PLoS ONE, 13(1), e0190118.PubMedPubMedCentral

23.

Escudero, D. J., Kerr, T., Operario, D., Socías, M. E., Sued, O., & Marshall, B. D. (2015). Inclusion of trans women in pre-exposure prophylaxis trials: A review. AIDS Care, 27(5), 637–641.PubMed

24.

Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016). Transgender women in clinical trials of pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes, 72(Suppl 3), S226.PubMed

25.

Sevelius, J. M., Deutsch, M. B., & Grant, R. (2016). The future of PrEP among transgender women: The critical role of gender affirmation in research and clinical practices. Journal of the International AIDS Society, 19, 21105.PubMedPubMedCentral

26.

Deutsch, M. B., Glidden, D. V., Sevelius, J., et al. (2015). HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e512–e519.PubMedPubMedCentral

27.

Marshall, B. D., & Mimiaga, M. J. (2015). Uptake and effectiveness of PrEP for transgender women. The Lancet HIV, 2(12), e502–e503.PubMedPubMedCentral

28.

Baeten, J. M. (2018). Amplifying the population health benefits of PrEP for HIV prevention. Journal of Infectious Diseases, 217(10), 1509–1511.PubMed

29.

Pasipanodya, E. C., Jain, S., Sun, X., et al. (2018). Trajectories and predictors of longitudinal PrEP adherence among men who have sex with men. The Journal of Infectious Diseases, 218, 1551–1559.PubMedPubMedCentral

30.

Centers for Disease Control and Prevention. (2018). HIV prevention pill not reaching most Americans who could benefit: Especially people of color. Press release. National center for HIV/AIDS, viral Hepatitis, STD, and TB prevention. Atlanta, GA: Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/nchhstp/newsroom/2018/croi-2018-PrEP-press-release.html.

31.

Conference on Retroviruses and Opportunistic Infections (CROI). (2018). PrEP at CROI 2018 report 2: Uptake, HIV incidence, barriers/challenges. Report from Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA.

32.

Rael, C. T., Martinez, M., Giguere, R., et al. (2018). Barriers and facilitators to oral PrEP use among transgender women in New York city. AIDS and Behavior, 22, 3627–3636.PubMedPubMedCentral

33.

Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health, 11(7–8), 1060–1075.PubMed

34.

Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681–3691.PubMedPubMedCentral

35.

Arnold, E. A., Hazelton, P., Lane, T., Christopoulos, K. A., Galindo, G. R., Steward, W. T., et al. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS ONE, 7(7), e40603.PubMedPubMedCentral

36.

Burns, D. N., Grossman, C., Turpin, J., Elharrar, V., & Veronese, F. (2014). Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies. Current HIV/AIDS Reports, 11(4), 393–403.PubMed

37.

Calabrese, S. K., Magnus, M., Mayer, K. H., et al. (2016). Putting PrEP into practice: Lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE, 11(6), e0157324.PubMedPubMedCentral

38.

Hosek, S., Celum, C., Wilson, C. M., Kapogiannis, B., Delany-Moretlwe, S., & Bekker, L. G. (2016). Preventing HIV among adolescents with oral PrEP: Observations and challenges in the United States and South Africa. Journal of the International AIDS Society, 19, 21107.PubMedPubMedCentral

39.

Underhill, K., Morrow, K. M., Colleran, C. M., et al. (2014). Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE, 9(11), e112425.PubMedPubMedCentral

40.

Wilton, J., Senn, H., Sharma, M., & Tan, D. H. (2015). Pre-exposure prophylaxis for sexually-acquired HIV risk management: A review. HIV/AIDS, 7, 125.PubMed

41.

Pathela, P., Jamison, K., Blank, S., et al. (2018). The PREP cascade at NYC sexual health clinics: Navigation is the key to uptake, in Presented at: Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA.

42.

Turner, R. J., & Turner, J. B. (1999). Social integration and support. Handbook of the sociology of mental health (pp. 301–319). Boston, MA: Springer.

43.

Veiel, H. O., & Baumann, U. (2014). The meaning and measurement of support. Abingdon: Taylor & Francis.

44.

Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education Quarterly, 11(1), 1–47.PubMed

45.

Bandura, A. (1991). Social cognitive theory of self-regulation. Organizational Behavior and Human Decision Processes, 50(2), 248–287.

46.

Bandura, A. (2001). Social cognitive theory: An agentic perspective. Annual Review of Psychology, 52(1), 1–26.PubMed

47.

Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs, 27(4), 248–254.PubMedPubMedCentral

48.

Levy, M. E., Wilton, L., Phillips, G., et al. (2014). Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States. AIDS and Behavior, 18(5), 972–996.PubMedPubMedCentral

49.

Hill, B. J., Crosby, R., Bouris, A., et al. (2018). Exploring transgender legal name change as a potential structural intervention for mitigating social determinants of health among transgender women of color. Sexuality Research and Social Policy, 15(1), 25–33.PubMed

50.

Clark, K., Fletcher, J. B., Holloway, I. W., & Reback, C. J. (2018). Structural inequities and social networks impact hormone use and misuse among transgender women in Los Angeles County. Archives of Sexual Behavior, 47(4), 953–962.PubMedPubMedCentral

51.

Reback, C. J., Fletcher, J. B., Shoptaw, S., & Mansergh, G. (2015). Exposure to theory-driven text messages is associated with HIV risk reduction among methamphetamine-using men who have sex with men. AIDS and Behavior, 19(2), 130–141.PubMed

52.

Reback, C. J., Fletcher, J. B., Swendeman, D. A., & Metzner, M. (2019). Theory-based text-messaging to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men: Automated unidirectional delivery outperforms bidirectional peer interactive delivery. AIDS and Behavior, 23(1), 37–47.PubMedPubMedCentral

53.

Reback, C. J., Grant, D. L., Fletcher, J. B., Branson, C. M., Shoptaw, S., Bowers, J. R., et al. (2012). Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS and Behavior, 16(7), 1993–2002.PubMedPubMedCentral

54.

Reback, C. J., Ling, D., Shoptaw, S., & Rohde, J. (2010). Developing a text messaging risk reduction intervention for methamphetamine-using MSM: Research note. The Open AIDS Journal, 4, 116.PubMedPubMedCentral

55.

Baams, L., Jonas, K. J., Utz, S., Bos, H. M., & Van Der Vuurst, L. (2011). Internet use and online social support among same sex attracted individuals of different ages. Computers in Human Behavior, 27(5), 1820–1827.

56.

Factor, R. J., & Rothblum, E. D. (2007). A study of transgender adults and their non-transgender siblings on demographic characteristics, social support, and experiences of violence. Journal of LGBT Health Research, 3(3), 11–30.PubMed

57.

Nemoto, T., Bödeker, B., & Iwamoto, M. (2011). Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work. American Journal of Public Health, 101(10), 1980–1988.PubMedPubMedCentral

58.

Puckett, J. A., Woodward, E. N., Mereish, E. H., & Pantalone, D. W. (2015). Parental rejection following sexual orientation disclosure: Impact on internalized homophobia, social support, and mental health. LGBT Health, 2(3), 265–269.PubMed

59.

Mayer, K. H., Chan, P. A., Patel, R., Flash, C. A., & Krakower, D. S. (2018). Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States. Journal of Acquired Immune Deficiency Syndromes, 77(2), 119.PubMed

60.

Bauman, L. J., Braunstein, S., Calderon, Y., et al. (2013). Barriers and facilitators of linkage to HIV primary care in New York City. Journal of Acquired Immune Deficiency Syndromes, 64(01), S20.PubMed

61.

Garcia, J., Colson, P. W., Parker, C., & Hirsch, J. S. (2015). Passing the baton: Community-based ethnography to design a randomized clinical trial on the effectiveness of oral pre-exposure prophylaxis for HIV prevention among black men who have sex with men. Contemporary Clinical Trials, 45, 244–251.PubMedPubMedCentral

62.

Parisi, D., Warren, B., Leung, S. J., et al. (2018). A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. Journal of the Association of Nurses in AIDS Care, 29(1), 10–19.PubMed

63.

Seelman, K. L., Colón-Diaz, M. J., LeCroix, R. H., Xavier-Brier, M., & Kattari, L. (2017). Transgender noninclusive healthcare and delaying care because of fear: Connections to general health and mental health among transgender adults. Transgender Health, 2(1), 17–28.PubMedPubMedCentral

64.

White Hughto, J. M., Murchison, G. R., Clark, K., Pachankis, J. E., & Reisner, S. L. (2016). Geographic and individual differences in healthcare access for US transgender adults: A multilevel analysis. LGBT Health, 3(6), 424–433.PubMedPubMedCentral

65.

Hughto, J. M. W., Reisner, S. L., & Pachankis, J. E. (2015). Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Social Science and Medicine, 147, 222–231.

66.

Dowshen, N., Kuhns, L. M., Gray, C., Lee, S., & Garofalo, R. (2013). Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV + youth. AIDS and Behavior, 17(6), 2237–2243.PubMed

67.

Dowshen, N., Kuhns, L. M., Johnson, A., Holoyda, B. J., & Garofalo, R. (2012). Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: A pilot study using personalized, interactive, daily text message reminders. Journal of Medical Internet Research, 14(2), e51.PubMedPubMedCentral

68.

Reback, C. J., Ruenger, D., Fletcher, J., et al. (2019). Text messaging to promote advancement along the HIV care continuum among young transgender women living with HIV, in Presented at: National HIV Prevention Conference, Atlanta, GA.

Titel: A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities
verfasst von: Cathy J. Reback
Kirsty A. Clark
Dennis Rünger
Anne E. Fehrenbacher
Publikationsdatum: 17.07.2019
Verlag: Springer US
Erschienen in: Journal of Community Health / Ausgabe 6/2019
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-019-00705-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles

Recent Survey Findings on Smoking and Cessation Behaviors Among Asians in New York City

Characterizing Occupational Health Risks and Chemical Exposures Among Asian Nail Salon Workers on the East Coast of the United States

Evaluation of a Pilot Intervention to Reduce Mental Health and Addiction Stigma in Primary Care Settings

A Systematic Review of Community Health Center Based Interventions for People with Diabetes

Outcomes and Lessons Learned from the Tribal Veterans Representative Program: A Model for System Engagement